Abstract
The levels of DNA methylation and their role in gene expression are key factors that could affect diagnosis, prognosis, and treatment options of different diseases. In this study, the methylation levels of 22 genes that are mostly correlated to breast cancer were determined using EpiTect methyl II PCR array. This analysis was performed to determine the effect of cells’ passage number and the use of antibiotics in the culturing media on gene methylation levels in MCF7 cell line. DNA methylation levels of PTGS2, ADAM23, HIC1, and PYCARD were found to be significantly different among different passages. While the DNA methylation levels of CCNA1, RASSF1, and THBS1 were found to be affected by the use of 1% of penicillin/streptomycin in the culture media. Gene expression analysis after demethylation using 5-Aza-2′-deoxycytidine showed that the gene expression levels of the hypermethylated genes varied between different passage numbers. This study shows that the presence of antibiotic within cultured media and cell line’s passage number could greatly affect the methylation levels that need to be considered in future studies on cell lines.
This is a preview of subscription content, log in via an institution to check access.
References
Angulo JC, Andrés G, Ashour N, Sánchez-Chapado M, López JI, Ropero S (2016) Development of castration resistant prostate cancer can be predicted by a DNA hypermethylation profile. J Urol 195(3):619–626. https://doi.org/10.1016/j.juro.2015.10.172
Benevolenskaya EV, Islam AB, Ahsan H, Kibriya MG, Jasmine F, Wolff B, Al-Alem U, Wiley E, Kajdacsy-Balla A, Macias V, Rauscher GH (2016) DNA methylation and hormone receptor status in breast cancer. Clin Epigenetics 8:17. https://doi.org/10.1186/s13148-016-0184-7 eCollection 2016
Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22(22):4632–4642
Foveau B, Boulay G, Pinte S, Van Rechem C, Rood BR, Leprince D (2012) The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1). J Biol Chem 287(8):5366–5378
Fridrichova I, Smolkova B, Kajabova V, Zmetakova I, Krivulcik T, Mego M, Cierna Z, Karaba M, Benca J, Pindak D, Bohac M, Repiska V, Danihel L (2015) CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers. Transl Res 165(6):717–730
Hayashi T, Hikichi M, Yukitake J, Harada N, Utsumi T (2017) Estradiol suppresses phosphorylation of ERα serine 167 through upregulation of PP2A in breast cancer cells. Oncol Lett 14(6):8060–8065. https://doi.org/10.3892/ol.2017.7216
Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N (2014) Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. Mod Pathol 27(6):906–915. https://doi.org/10.1038/modpathol.2013.204
Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ (2007) Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 67(24):11517–11527
Kinarivala N, Shah K, Abbruscato TJ, Trippier PC (2017) Passage variation of PC12 cells results in inconsistent susceptibility to externally induced apoptosis. ACS Chem Neurosci 8(1):82–88. https://doi.org/10.1021/acschemneuro.6b00208
Klajic J, Busato F, Edvardsen H, Touleimat N, Fleischer T, Bukholm I, Børresen-Dale AL, Lønning PE, Tost J, Kristensen VN (2014) DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors. Clin Cancer Res 20(24):6357–6366. https://doi.org/10.1158/1078-0432.CCR-14-0297
Kwist K, Bridges WC, Burg KJ (2016) The effect of cell passage number on osteogenic and castration characteristics of D1 cells. Cytotechnology 68(4):1661–1667. https://doi.org/10.1007/s10616-015-9883-8
Levine JJ, Stimson-Crider KM, Vertino PM (2003) Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Oncogene 22(22):3475–3488
Mawlood SK, Dennany L, Watson N, Pickard BS (2016) The EpiTect Methyl qPCR Assay as novel age estimation method in forensic biology. Forensic Sci Int 264:132–138. https://doi.org/10.1016/j.forsciint.2016.03.047
Panahi Y, Beiraghdar F, Amirhamzeh A, Poursaleh Z, Saadat A, Sahebkar A (2015) Environmental toxicant exposure and cancer: the role of epigenetic changes and protection by phytochemicals. Curr Pharm Des 22(2):130–140
Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S (2010) Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res 70(3):968–978
Roll JD, Rivenbark AG, Jones WD, Coleman WB (2008) DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 7:15
Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD (2006) A genome-wide screen for promoter methylation in lung cancer identifies novel methylationmarkers for multiple malignancies. PLoS Med 3(12):e486
Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B (2016) Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics 8:115 eCollection 2016 67(24):11517–27
Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knuchel R, Dahl E (2008) Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol Cancer 7:83
Wagner E, Wu W, Liu Y, Nephew K, Han J, He C (2016) Abstract A51: DNA methylation in tumor, adjacent non-tumorous and normal breast tissues. Cancer Res 76(2 Supplement):A51
Xu J, Shetty PB, Feng W, Chenault C, Bast RC, Issa JPJ, Hilsenbeck SG, Yu Y (2012) Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. BMC Cancer 12(1):1–7
Xue M, Lai SC, Xu ZP, Wang LJ (2015) Noninvasive DNA methylation biomarkers in colorectal cancer: a systematic review. J Dig Dis 16(12):699–712
Zhang J, Wang J, Xing H, Li Q, Zhao Q, Li J (2016) Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells. Mol Cell Biochem 411(1–2):331–340
Zheng J, Xiong D, Sun X, Wang J, Hao M, Ding T, Xiao G, Wang X, Mao Y, Fu Y, Shen K (2012) Signification of hypermethylated in cancer 1 (HIC1) as tumor suppressor gene in tumor progression. Cancer Microenviron 5(3):285–293
Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, Shen JH, Xu LY, Li EM (2009) Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 9(1):1–8
Funding
This study received a financial support from Al-Zaytoonah University of Jordan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Editor: Tetsuji Okamoto
Rights and permissions
About this article
Cite this article
Hamadneh, L., Al-Majawleh, M., Jarrar, Y. et al. Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line. In Vitro Cell.Dev.Biol.-Animal 54, 331–334 (2018). https://doi.org/10.1007/s11626-018-0245-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-018-0245-7